Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | Unknown | — |
The patient took first two doses of Vivotif two days in a row; Case reference number US-BN-2024-002328 is a spontaneous case initially received from nurse via agency (reference number USBAV24-1927) on 09-Aug-2024 and concerns a *61-year-old* female patient. The patient's medical history and concomitant medication details were not provided. *On 18-Jul-2024, the patient took the first dose of Vivotif (batch number: 3004044, expiry date: 30-Nov-2024), four capsules, via oral use, as reported for travel vaccine* On an unspecified date, *reported as one day after the first dose, the patient took the second dose of Vivotif (batch number: unknown), at an unknown dose, via unknown route (explicitly coded as 'Inappropriate schedule of vaccine administered').* At the time of the *follow up report*, the patient *did not experience* any adverse event due to Vivotif vaccine. All follow-up information is blended into the case narrative above, with the latest information presented between asterisks (*). Follow up information received from a nurse on 23-Aug-2024: New information included added patient age, Vivotif dosage information and confirmation that the patient did not experience any adverse event. Non-significant follow-up was downloaded from VAERS on 09-May-2025 included new reference number. Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240809-851555 to US-BAVARIAN NORDIC A/S-US-BN-2024-002328, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A 61-year-old female patient received her first Vivotif doses, two days in a row, which is considered inappropriate schedule of vaccine administered. The patient did not experience any adverse event due to Vivotif vaccine. Inappropriate schedule of vaccine administered is listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to Vivotif, but to a human error. The case is non-serious.; Sender's Comments: A 61-year-old female patient received her first Vivotif doses, two days in a row, which is considered inappropriate schedule of vaccine administered. The patient did not experience any adverse event due to Vivotif vaccine. Inappropriate schedule of vaccine administered is listed per company convention. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of vaccine administered is not related to Vivotif, but to a human error. The case is non-serious.
Comments: None